NCT01591174

Brief Summary

The purpose of this research is to see if there are differences between children who have FD and children without FD in the ability of the stomach to empty food and/or in ghrelin hormone levels before and after eating. Chronic abdominal pain is the most common persistent pain condition in children and adolescents. One of the most often diagnosed types of abdominal pain is functional dyspepsia (FD). FD is abdominal pain or discomfort (e.g., nausea, bloating) in the upper abdomen that does not get better by having a bowel movement. One possible explanation for having FD is a delay in the emptying of food from the stomach, or delayed gastric (stomach) emptying. Failing to empty the stomach quickly enough may result in the feeling of being full and cause symptoms of bloating, nausea, vomiting and pain. Further, hormonal changes occur before, during, or after eating food that appear to impact stomach emptying. One of the hormones that changes with meals is called ghrelin. The relationship between ghrelin and stomach emptying needs to be explored more in children with FD. Better understanding of what causes FD symptoms may help us to improve treatment for this condition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2012

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

May 2, 2012

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 3, 2012

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 22, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 22, 2016

Completed
Last Updated

May 20, 2019

Status Verified

May 1, 2019

Enrollment Period

4 years

First QC Date

May 2, 2012

Last Update Submit

May 16, 2019

Conditions

Keywords

Functional DyspepsiaPostprandial Distress SyndromeghrelinC-13 acetate

Outcome Measures

Primary Outcomes (1)

  • Children with FD: exploration of relationships between ghrelin concentration, liquid gastric emptying, and dyspepsia subtype

    Blood samples will be compared pre/post test meal for FD cohorts (EPS/PDS), controls: 0 time/baseline; 6 times/post meal. Associations between relationship of plasma ghrelin type's (acyl and desacyl) pre and postprandial levels \& gastric emptying studied.C-13 acetate to be given and amount of 13CO2 determined for each time point (1 pre/ 14 post meal) using equation nested in software package with UBit IR-300 spectrometer. The concentration of 13CO2 and 12CO2 in the exhaled breath samples to be measured by infrared spectrometry.

    Duration of 4-hour study visit

Secondary Outcomes (1)

  • Children with FD: SUBJECTIVE SYMPTOM SEVERITY and correlations between plasma ghrelin concentrations (acyl and desacyl) and gastric emptying.

    Duration of 4-hour study visit

Study Arms (3)

Functional Dyspepsia with PDS

Study participants 8-17 years of age will be recruited for this arm after an evaluation at Children's Mercy Hospital and Clinics in the Abdominal Pain Clinic (APC)or in the Section of Gastroenterology, general, and diagnosed with FD, fail to respond to acid suppression therapy and have Postprandial Distress Syndrome (PDS).

Functional Dyspepsia without PDS

Study participants 8-17 years of age will be recruited for this arm after an evaluation at Children's Mercy Hospital and clinics (CMH) Abdominal Pain Clinic (APC)or the Section of Gastroenterology, general, and diagnosed with FD, fail to respond to acid suppression therapy and do not have Postprandial Distress Syndrome (PDS).

Control Group

Healthy participants 8-17 years of age recruited from internal advertising within Children's Mercy Hospital and Clinics.

Eligibility Criteria

Age8 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

All FD patients will be recruited from the Section of Gastroenterology at the Children's Mercy Hospital and Clinics. The control group will be recruited by advertisement within Children's Mercy Hospital.

You may qualify if:

  • All: Participants 8-17 years of age

You may not qualify if:

  • History of upper gastrointestinal surgery or intestinal obstruction.
  • History of disease or symptoms suggestive of underlying malabsorption, Inflammatory Bowel Disease (IBD), or Peptic Ulcer Disease (PUD).
  • History or evidence of chronic illness requiring regular medical care such as diabetes mellitis (DM), liver, heart, kidney, endocrine, or pulmonary disease and asthma that precludes accurate exhalation into the study breath collection apparatus.
  • Any patient with body Mass index (BMI) less than or equal to 10th percentile for age; or equal to or greater than 90th percentile for age.
  • Patient and/or parent not able to read English.
  • Current pregnancy.
  • History of milk allergy.
  • Prokinetic or psychotropic medications used within the last 72 hour prior to study.
  • Inability to exhale into study breath collection apparatus as directed.
  • Recent acute illness that occurs prior to study visit.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Mercy Hospital

Kansas City, Missouri, 64108, United States

Location

Related Publications (35)

  • Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006 Apr;130(5):1377-90. doi: 10.1053/j.gastro.2006.03.008. No abstract available.

    PMID: 16678553BACKGROUND
  • Suzuki H, Nishizawa T, Hibi T. Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification. J Gastroenterol. 2006 Jun;41(6):513-23. doi: 10.1007/s00535-006-1847-5.

    PMID: 16868798BACKGROUND
  • Akamizu T, Iwakura H, Ariyasu H, Kangawa K. Ghrelin and functional dyspepsia. Int J Pept. 2010;2010:548457. doi: 10.1155/2010/548457. Epub 2010 Jan 12.

    PMID: 20721353BACKGROUND
  • Schurman JV, Singh M, Singh V, Neilan N, Friesen CA. Symptoms and subtypes in pediatric functional dyspepsia: relation to mucosal inflammation and psychological functioning. J Pediatr Gastroenterol Nutr. 2010 Sep;51(3):298-303. doi: 10.1097/MPG.0b013e3181d1363c.

    PMID: 20479684BACKGROUND
  • Castillo EJ, Camilleri M, Locke GR, Burton DD, Stephens DA, Geno DM, Zinsmeister AR. A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia. Clin Gastroenterol Hepatol. 2004 Nov;2(11):985-96. doi: 10.1016/s1542-3565(04)00454-9.

    PMID: 15551251BACKGROUND
  • Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993 Sep;38(9):1569-80. doi: 10.1007/BF01303162.

    PMID: 8359066BACKGROUND
  • Schurman JV, Friesen CA, Danda CE, Andre L, Welchert E, Lavenbarg T, Cocjin JT, Hyman PE. Diagnosing functional abdominal pain with the Rome II criteria: parent, child, and clinician agreement. J Pediatr Gastroenterol Nutr. 2005 Sep;41(3):291-5. doi: 10.1097/01.mpg.0000178438.64675.c4.

    PMID: 16131983BACKGROUND
  • Hyams JS, Hyman PE. Recurrent abdominal pain and the biopsychosocial model of medical practice. J Pediatr. 1998 Oct;133(4):473-8. doi: 10.1016/s0022-3476(98)70053-8. No abstract available.

    PMID: 9787683BACKGROUND
  • Takamori K, Mizuta Y, Takeshima F, Akazawa Y, Isomoto H, Ohnita K, Ohba K, Omagari K, Shikuwa S, Kohno S. Relation among plasma ghrelin level, gastric emptying, and psychologic condition in patients with functional dyspepsia. J Clin Gastroenterol. 2007 May-Jun;41(5):477-83. doi: 10.1097/01.mcg.0000225614.94470.47.

    PMID: 17450030BACKGROUND
  • Ogiso K, Asakawa A, Amitani H, Inui A. Ghrelin: a gut hormonal basis of motility regulation and functional dyspepsia. J Gastroenterol Hepatol. 2011 Apr;26 Suppl 3:67-72. doi: 10.1111/j.1440-1746.2011.06630.x.

    PMID: 21443713BACKGROUND
  • Riezzo G, Chiloiro M, Guerra V, Borrelli O, Salvia G, Cucchiara S. Comparison of gastric electrical activity and gastric emptying in healthy and dyspeptic children. Dig Dis Sci. 2000 Mar;45(3):517-24. doi: 10.1023/a:1005493123557.

    PMID: 10749327BACKGROUND
  • Heyman S. Gastric emptying in children. J Nucl Med. 1998 May;39(5):865-9.

    PMID: 9591590BACKGROUND
  • Hou XH, Li Q, Zhu L, Xie X, Chen JD. Correlation of gastric liquid emptying with various thresholds of sensation in healthy controls and patients with functional dyspepsia. Dig Dis Sci. 2004 Feb;49(2):188-95. doi: 10.1023/b:ddas.0000017437.20932.8b.

    PMID: 15104356BACKGROUND
  • Maes BD, Ghoos YF, Geypens BJ, Hiele MI, Rutgeerts PJ. Relation between gastric emptying rate and energy intake in children compared with adults. Gut. 1995 Feb;36(2):183-8. doi: 10.1136/gut.36.2.183.

    PMID: 7883214BACKGROUND
  • Jones BL, Pearce RE, Abdel-Rahman SM, Friesen CA, James LP, Kearns GL. Characterization of delayed liquid gastric emptying in children by the (13)C-acetate breath test. J Breath Res. 2009 Dec;3(4):047004. doi: 10.1088/1752-7155/3/4/047004. Epub 2009 Nov 27.

    PMID: 21386201BACKGROUND
  • Braden B, Adams S, Duan LP, Orth KH, Maul FD, Lembcke B, Hor G, Caspary WF. The [13C]acetate breath test accurately reflects gastric emptying of liquids in both liquid and semisolid test meals. Gastroenterology. 1995 Apr;108(4):1048-55. doi: 10.1016/0016-5085(95)90202-3.

    PMID: 7698571BACKGROUND
  • Hauser B, De Schepper J, Caveliers V, Salvatore S, Salvatoni A, Vandenplas Y. Variability of the 13C-acetate breath test for gastric emptying of liquids in healthy children. J Pediatr Gastroenterol Nutr. 2006 Apr;42(4):392-7. doi: 10.1097/01.mpg.0000215306.40546.17.

    PMID: 16641577BACKGROUND
  • Barbosa L, Vera H, Moran S, Del Prado M, Lopez-Alarcon M. Reproducibility and reliability of the 13C-acetate breath test to measure gastric emptying of liquid meal in infants. Nutrition. 2005 Mar;21(3):289-94. doi: 10.1016/j.nut.2004.05.027.

    PMID: 15797668BACKGROUND
  • Gatti C, di Abriola FF, Dall'Oglio L, Villa M, Franchini F, Amarri S. Is the 13C-acetate breath test a valid procedure to analyse gastric emptying in children? J Pediatr Surg. 2000 Jan;35(1):62-5. doi: 10.1016/s0022-3468(00)80015-9.

    PMID: 10646776BACKGROUND
  • Ueno H, Shiiya T, Nakazato M. Translational research of ghrelin. Ann N Y Acad Sci. 2010 Jul;1200:120-7. doi: 10.1111/j.1749-6632.2010.05509.x.

    PMID: 20633140BACKGROUND
  • Chanoine JP. Ghrelin in growth and development. Horm Res. 2005;63(3):129-38. doi: 10.1159/000084688. Epub 2005 Mar 24.

    PMID: 15795510BACKGROUND
  • Tack J, Depoortere I, Bisschops R, Delporte C, Coulie B, Meulemans A, Janssens J, Peeters T. Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut. 2006 Mar;55(3):327-33. doi: 10.1136/gut.2004.060426. Epub 2005 Oct 10.

    PMID: 16216827BACKGROUND
  • Lee KJ, Cha DY, Cheon SJ, Yeo M, Cho SW. Plasma ghrelin levels and their relationship with gastric emptying in patients with dysmotility-like functional dyspepsia. Digestion. 2009;80(1):58-63. doi: 10.1159/000215389. Epub 2009 Jun 3.

    PMID: 19494492BACKGROUND
  • Shindo T, Futagami S, Hiratsuka T, Horie A, Hamamoto T, Ueki N, Kusunoki M, Miyake K, Gudis K, Tsukui T, Iwakiri K, Sakamoto C. Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and non-erosive reflux disease. Digestion. 2009;79(2):65-72. doi: 10.1159/000205740. Epub 2009 Feb 27.

    PMID: 19246923BACKGROUND
  • Fukuda H, Mizuta Y, Isomoto H, Takeshima F, Ohnita K, Ohba K, Omagari K, Taniyama K, Kohno S. Ghrelin enhances gastric motility through direct stimulation of intrinsic neural pathways and capsaicin-sensitive afferent neurones in rats. Scand J Gastroenterol. 2004 Dec;39(12):1209-14.

    PMID: 15742997BACKGROUND
  • Trudel L, Tomasetto C, Rio MC, Bouin M, Plourde V, Eberling P, Poitras P. Ghrelin/motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat. Am J Physiol Gastrointest Liver Physiol. 2002 Jun;282(6):G948-52. doi: 10.1152/ajpgi.00339.2001.

    PMID: 12016119BACKGROUND
  • Heath RB, Jones R, Frayn KN, Robertson MD. Vagal stimulation exaggerates the inhibitory ghrelin response to oral fat in humans. J Endocrinol. 2004 Feb;180(2):273-81. doi: 10.1677/joe.0.1800273.

    PMID: 14765979BACKGROUND
  • Lin Z, Eaker EY, Sarosiek I, McCallum RW. Gastric myoelectrical activity and gastric emptying in patients with functional dyspepsia. Am J Gastroenterol. 1999 Sep;94(9):2384-9. doi: 10.1111/j.1572-0241.1999.01362.x.

    PMID: 10483996BACKGROUND
  • Valera Mora ME, Scarfone A, Valenza V, Calvani M, Greco AV, Gasbarrini G, Mingrone G. Ghrelin does not influence gastric emptying in obese subjects. Obes Res. 2005 Apr;13(4):739-44. doi: 10.1038/oby.2005.83.

    PMID: 15897483BACKGROUND
  • Wren AM, Bloom SR. Gut hormones and appetite control. Gastroenterology. 2007 May;132(6):2116-30. doi: 10.1053/j.gastro.2007.03.048.

    PMID: 17498507BACKGROUND
  • Akamizu T, Iwakura H, Ariyasu H, Hosoda H, Murayama T, Yokode M, Teramukai S, Seno H, Chiba T, Noma S, Nakai Y, Fukunaga M, Nakai Y, Kangawa K; FD Clinical Study Team. Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite. Eur J Endocrinol. 2008 Apr;158(4):491-8. doi: 10.1530/EJE-07-0768.

    PMID: 18362296BACKGROUND
  • Ejskjaer N, Dimcevski G, Wo J, Hellstrom PM, Gormsen LC, Sarosiek I, Softeland E, Nowak T, Pezzullo JC, Shaughnessy L, Kosutic G, McCallum R. Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study. Neurogastroenterol Motil. 2010 Oct;22(10):1069-e281. doi: 10.1111/j.1365-2982.2010.01519.x. Epub 2010 Jun 28.

    PMID: 20524987BACKGROUND
  • Tack J, Depoortere I, Bisschops R, Verbeke K, Janssens J, Peeters T. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment Pharmacol Ther. 2005 Nov 1;22(9):847-53. doi: 10.1111/j.1365-2036.2005.02658.x.

    PMID: 16225494BACKGROUND
  • Ang D, Nicolai H, Vos R, Mimidis K, Akyuz F, Kindt S, Vanden Berghe P, Sifrim D, Depoortere I, Peeters T, Tack J. Influence of ghrelin on the gastric accommodation reflex and on meal-induced satiety in man. Neurogastroenterol Motil. 2009 May;21(5):528-33, e8-9. doi: 10.1111/j.1365-2982.2008.01239.x. Epub 2008 Jan 30.

    PMID: 19210631BACKGROUND
  • Nishizawa T, Suzuki H, Nomoto Y et al. Enhanced plasma ghrelin levels in patients with functional dyspepsia. Aliment. Pharmacol. Ther. 2006; 24 (Suppl. 4): 104-10. 02.01.12

    BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

breath specimen blood plasma

Study Officials

  • Nadia M Hijaz, MD

    Fellow, Children's Mercy Hospital, Section of Gastroenterology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Fellow, Children's Mercy Hospital, Section of Gastroenterology

Study Record Dates

First Submitted

May 2, 2012

First Posted

May 3, 2012

Study Start

May 1, 2012

Primary Completion

April 22, 2016

Study Completion

April 22, 2016

Last Updated

May 20, 2019

Record last verified: 2019-05

Locations